F. Hoffmann-La Roche AG
Papers in the tracked journals with an author at F. Hoffmann-La Roche AG: per year and category, where they are published, the institutions its researchers write with, and its most-cited papers. A paper counts as corporate when at least one of its authors is affiliated with an institution that OpenAlex classifies as a company; it counts once for each company among its authors' affiliations. Universities are the institutions OpenAlex classifies as education. Also as Markdown.
Key findings#
- From 2017 to 2026 (so far), authors at F. Hoffmann-La Roche AG took part in 43 papers in the tracked journals, most of them in health economics and policy (32), AI (6) and statistics (3).
- It ranks #37 among the companies publishing in the tracked journals from 2023 to 2025.
- 7 of them were published in 2025, against 1 in 2017.
- Since 2023, the institutions with the most of these papers were Genentech (4), University of Warwick (4) and University of Bern (3).
- The journals publishing most of them were PharmacoEconomics (6), PharmacoEconomics - Open (5) and Nature Machine Intelligence (3).
- The most-cited of them is “A Survey on Causal Discovery: Theory and Practice” (International Journal of Approximate Reasoning, 2022), with 122 citations.
Papers per year#
20172026 (so far)
| Category | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (so far) |
|---|---|---|---|---|---|---|---|---|---|---|
| Health Economics and Policy | 1 | 2 | 0 | 1 | 7 | 6 | 4 | 6 | 3 | 2 |
| AI | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 2 | 0 |
| Statistics | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 0 |
| Higher Education and Research | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Management | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| All categories | 1 | 2 | 0 | 2 | 8 | 7 | 7 | 7 | 7 | 2 |
Where the papers come from#
| # | Journal | Papers |
|---|---|---|
| 1 | PharmacoEconomics | 6 |
| 2 | PharmacoEconomics - Open | 5 |
| 3 | Nature Machine Intelligence | 3 |
| 4 | Applied Health Economics and Health Policy | 2 |
| 5 | Journal of Multivariate Analysis | 1 |
| 6 | Health Policy | 1 |
| 7 | Knowledge and Information Systems | 1 |
| 8 | Expert Systems with Applications | 1 |
| 9 | Statistics and Computing | 1 |
| 10 | Lifetime Data Analysis | 1 |
| # | Institution | Papers |
|---|---|---|
| 1 | Genentech | 4 |
| 2 | University of Warwick | 4 |
| 3 | University of Bern | 3 |
| 4 | University of Washington | 3 |
| 5 | University of York | 3 |
| 6 | Inserm | 2 |
| 7 | Karolinska Institutet | 2 |
| 8 | Lund University | 2 |
| 9 | Novartis (Switzerland) | 2 |
| # | Country | Papers |
|---|---|---|
| 1 | Switzerland | 23 |
| 2 | United Kingdom | 11 |
| 3 | United States | 9 |
| 4 | Sweden | 5 |
| 5 | Germany | 4 |
| 6 | Canada | 3 |
| 7 | France | 3 |
| 8 | Belgium | 2 |
| 9 | Spain | 2 |
| 10 | Netherlands | 2 |
| # | Keyword | Papers |
|---|---|---|
| 1 | health technology assessment | 4 |
| 2 | non-small cell lung cancer | 4 |
| 3 | adjuvant therapy | 3 |
| 4 | cost-effectiveness | 3 |
| 5 | early-stage lung cancer | 3 |
| 6 | health care costs | 3 |
| 7 | quality-adjusted life years | 3 |
| 8 | cost drivers | 2 |
| 9 | direct medical costs | 2 |
| 10 | disease progression | 2 |
Most-cited papers#
Cite this page
Scholar4AI. (2026). F. Hoffmann-La Roche AG. Journal Research Rankings. Retrieved October 31, 2026, from https://scholar4ai.com/companies/f-hoffmann-la-roche-ag
@misc{scholar4ai-companies-f-hoffmann-la-roche-ag,
author = {{Scholar4AI}},
title = {F. Hoffmann-La Roche AG},
year = {2026},
howpublished = {\url{https://scholar4ai.com/companies/f-hoffmann-la-roche-ag}},
urldate = {2026-10-31},
note = {Journal Research Rankings; data from OpenAlex (CC0); licensed CC BY-NC 4.0}
}